News
07-12-2010, 04:11 AM
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that a manuscript based on a study of Clarient InsightDx Mammostrat, a test used to classify the risk of recurrence of breast cancer following surgery and chemotherapy, will be published in an upcoming edition of Breast Cancer Research, a prominent peer-reviewed medical journal.
More... (http://www.news-medical.net/news/20100712/Manuscript-based-on-study-of-Clarient-InsightDx-Mammostrat-to-be-published-in-Breast-Cancer-Research.aspx)
More... (http://www.news-medical.net/news/20100712/Manuscript-based-on-study-of-Clarient-InsightDx-Mammostrat-to-be-published-in-Breast-Cancer-Research.aspx)